CN105797131A - 硒肽纳米自乳化粉剂、其制备方法和应用 - Google Patents
硒肽纳米自乳化粉剂、其制备方法和应用 Download PDFInfo
- Publication number
- CN105797131A CN105797131A CN201610255289.0A CN201610255289A CN105797131A CN 105797131 A CN105797131 A CN 105797131A CN 201610255289 A CN201610255289 A CN 201610255289A CN 105797131 A CN105797131 A CN 105797131A
- Authority
- CN
- China
- Prior art keywords
- selenium
- preparation
- water
- nanometer self
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 95
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 95
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 78
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 71
- 239000000843 powder Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 31
- 239000005017 polysaccharide Substances 0.000 claims abstract description 31
- 229920001184 polypeptide Polymers 0.000 claims abstract description 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 150000004676 glycans Chemical class 0.000 claims abstract description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 37
- 239000012071 phase Substances 0.000 claims description 29
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 27
- -1 selenium polysaccharide Chemical class 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 23
- 108010073771 Soybean Proteins Proteins 0.000 claims description 14
- 235000019710 soybean protein Nutrition 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 12
- 239000004064 cosurfactant Substances 0.000 claims description 11
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 11
- 239000012498 ultrapure water Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000007764 o/w emulsion Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 210000000481 breast Anatomy 0.000 claims description 7
- 239000003431 cross linking reagent Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000012298 atmosphere Substances 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 239000004530 micro-emulsion Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- STORWMDPIHOSMF-UHFFFAOYSA-N decanoic acid;octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O STORWMDPIHOSMF-UHFFFAOYSA-N 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 241001474374 Blennius Species 0.000 claims description 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000002736 nonionic surfactant Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 229940091258 selenium supplement Drugs 0.000 description 76
- 239000003921 oil Substances 0.000 description 30
- 239000007908 nanoemulsion Substances 0.000 description 14
- 238000013470 microfluidic resistive pulse sensing Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 238000013019 agitation Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000004567 concrete Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000010413 mother solution Substances 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005979 thermal decomposition reaction Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 2
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 108010036012 Iodide peroxidase Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- KKCIOUWDFWQUBT-AWEZNQCLSA-N L-thyronine Chemical compound C1=CC(C[C@H](N)C(O)=O)=CC=C1OC1=CC=C(O)C=C1 KKCIOUWDFWQUBT-AWEZNQCLSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical group OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000017712 iodothyronine deiodinase Human genes 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610255289.0A CN105797131B (zh) | 2016-04-22 | 2016-04-22 | 硒肽纳米自乳化粉剂、其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610255289.0A CN105797131B (zh) | 2016-04-22 | 2016-04-22 | 硒肽纳米自乳化粉剂、其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105797131A true CN105797131A (zh) | 2016-07-27 |
CN105797131B CN105797131B (zh) | 2019-06-18 |
Family
ID=56458387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610255289.0A Active CN105797131B (zh) | 2016-04-22 | 2016-04-22 | 硒肽纳米自乳化粉剂、其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105797131B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110664755A (zh) * | 2019-11-06 | 2020-01-10 | 周华锋 | 一种蛋白质多肽自微乳及其制备方法与应用 |
CN110973637A (zh) * | 2019-10-30 | 2020-04-10 | 安徽中谷生物科技有限公司 | 一种植物小分子有机硒的制备方法 |
CN111264874A (zh) * | 2020-03-10 | 2020-06-12 | 江西省农业科学院农产品质量安全与标准研究所 | 一种富硒凝胶乳液及制备方法、富硒酱牛肉及加工方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104646A (zh) * | 2007-05-31 | 2008-01-16 | 暨南大学 | 硒化琼枝麒麟菜多糖的制备方法及应用 |
CN102076223A (zh) * | 2008-06-24 | 2011-05-25 | 雀巢产品技术援助有限公司 | 美拉德风味组合物及此类组合物的制备方法 |
-
2016
- 2016-04-22 CN CN201610255289.0A patent/CN105797131B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104646A (zh) * | 2007-05-31 | 2008-01-16 | 暨南大学 | 硒化琼枝麒麟菜多糖的制备方法及应用 |
CN102076223A (zh) * | 2008-06-24 | 2011-05-25 | 雀巢产品技术援助有限公司 | 美拉德风味组合物及此类组合物的制备方法 |
Non-Patent Citations (2)
Title |
---|
徐珂珂: "大豆蛋白与多糖复合物乳化性质的研究", 《CNKI中国优秀硕士学位论文全文数据库,工程科技I辑,复旦大学大学硕士学位论文》 * |
李显春等: "硒多糖的研究进展", 《湖北民族学院学报(自然科学版)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110973637A (zh) * | 2019-10-30 | 2020-04-10 | 安徽中谷生物科技有限公司 | 一种植物小分子有机硒的制备方法 |
CN110664755A (zh) * | 2019-11-06 | 2020-01-10 | 周华锋 | 一种蛋白质多肽自微乳及其制备方法与应用 |
CN110664755B (zh) * | 2019-11-06 | 2021-11-05 | 周华锋 | 一种蛋白质多肽自微乳及其制备方法与应用 |
CN111264874A (zh) * | 2020-03-10 | 2020-06-12 | 江西省农业科学院农产品质量安全与标准研究所 | 一种富硒凝胶乳液及制备方法、富硒酱牛肉及加工方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105797131B (zh) | 2019-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qin et al. | Enhancing the storage and gastrointestinal passage viability of probiotic powder (Lactobacillus Plantarum) through encapsulation with pickering high internal phase emulsions stabilized with WPI-EGCG covalent conjugate nanoparticles | |
CN105639651B (zh) | 多酚-蛋白质/多肽-碳水化合物共价复合物的制备方法和应用 | |
Jiang et al. | Edible high internal phase Pickering emulsion with double-emulsion morphology | |
CN105797131A (zh) | 硒肽纳米自乳化粉剂、其制备方法和应用 | |
Ding et al. | Gelatin-stabilized traditional emulsions: Emulsion forms, droplets, and storage stability | |
CN103813786A (zh) | 用于局部递送的蛋白纳米载体 | |
Le Roux et al. | Plant proteins partially replacing dairy proteins greatly influence infant formula functionalities | |
KR0163216B1 (ko) | 생체에 유용한 철(ii)을 함유한 리포좀 및 그 제조방법 | |
CN104324380A (zh) | 一种纳米药物载体及其制备方法和应用 | |
CN105054073B (zh) | 一种水溶性的维生素d3纳米颗粒及其制备方法 | |
WO2009101612A2 (en) | Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof | |
CN107595809A (zh) | 一种玉米醇溶蛋白纳米包埋缓释填充物及其制备方法 | |
Yan et al. | Utilization of polysaccharide-based high internal phase emulsion for nutraceutical encapsulation: Enhancement of carotenoid loading capacity and stability | |
Wang et al. | Improved encapsulation capacity of casein micelles with modified structure | |
CN109260177A (zh) | 一种盐酸小檗碱复合物纳米粒的制备方法及其应用 | |
Israeli-Lev et al. | Harnessing proteins to control crystal size and morphology, for improved delivery performance of hydrophobic bioactives, using genistein as a model | |
Sun et al. | Pickering emulsions stabilized by reassembled oleosome protein nanoparticles for co-encapsulating hydrophobic nutrients | |
KR101199751B1 (ko) | 유단백질을 함유하는 철 조성물 | |
Zhang et al. | Lycopene-loaded emulsions stabilized by whey protein covalently modified with pectin or/and chlorogenic acid: Enhanced physicochemical stability and reduced bio-accessibility | |
Liang et al. | W/O/W emulsions stabilized with whey protein concentrate and pectin: Effects on storage, pasteurization, and gastrointestinal viability of Lacticaseibacillus rhamnosus | |
Yang et al. | Physicochemical stability of Pickering emulsion stabilized with spherical and fibrous iron ions loaded whey protein isolate/gum Arabic complexes | |
CN1366877A (zh) | 中药挥发油自乳化释药系统 | |
ES2868955T3 (es) | Tratamiento médico que comprende la administración enteral de edaravona | |
CN103931785B (zh) | 食品级月见草油微乳冻干粉及其制备方法 | |
CN113875979B (zh) | 一种食品级油水双相负载乳液凝胶运载体系的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190917 Address after: 233000 Yudu Avenue South Side 8, Huaiyuan Economic Development Zone, Bengbu City, Anhui Province Patentee after: ANHUI ZHONGGU BIOTECHNOLOGY Co.,Ltd. Address before: Suzhou City, Jiangsu Province, Suzhou Industrial Park 215000 Xinghu Street No. 999 building 99 room 1510 Patentee before: SEKING (SUZHOU) BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240613 Address after: 233400 North side of Jiankang West Road and east side of Z7 Road in Bailianpo Science and Technology Industrial Park, Huaiyuan County, Bengbu City, Anhui Province Patentee after: Anhui Zhongzhi Modern Food Technology Co.,Ltd. Country or region after: China Address before: No. 8, South Side of Yudu Avenue, Economic Development Zone, Huaiyuan County, Bengbu City, Anhui Province, 233000 Patentee before: ANHUI ZHONGGU BIOTECHNOLOGY Co.,Ltd. Country or region before: China |